Role of polyamines at the G1/S boundary and G2/M phase of the cell cycle

Int J Biochem Cell Biol. 2013 Jun;45(6):1042-50. doi: 10.1016/j.biocel.2013.02.021. Epub 2013 Mar 14.

Abstract

The role of polyamines at the G1/S boundary and in the G2/M phase of the cell cycle was studied using synchronized HeLa cells treated with thymidine or with thymidine and aphidicolin. Synchronized cells were cultured in the absence or presence of α-difluoromethylornithine (DFMO), an inhibitor of ornithine decarboxylase, plus ethylglyoxal bis(guanylhydrazone) (EGBG), an inhibitor of S-adenosylmethionine decarboxylase. When polyamine content was reduced by treatment with DFMO and EGBG, the transition from G1 to S phase was delayed. In parallel, the level of p27(Kip1) was greatly increased, so its mechanism was studied in detail. Synthesis of p27(Kip1) was stimulated at the level of translation by a decrease in polyamine levels, because of the existence of long 5'-untranslated region (5'-UTR) in p27(Kip1) mRNA. Similarly, the transition from the G2/M to the G1 phase was delayed by a reduction in polyamine levels. In parallel, the number of multinucleate cells increased by 3-fold. This was parallel with the inhibition of cytokinesis due to an unusual distribution of actin and α-tubulin at the M phase. Since an association of polyamines with chromosomes was not observed by immunofluorescence microscopy at the M phase, polyamines may have only a minor role in structural changes of chromosomes at the M phase. In general, the involvement of polyamines at the G2/M phase was smaller than that at the G1/S boundary.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosylmethionine Decarboxylase / antagonists & inhibitors
  • Adenosylmethionine Decarboxylase / metabolism
  • Biogenic Polyamines / metabolism*
  • Cell Division / drug effects
  • Cell Division / physiology*
  • Cyclin-Dependent Kinase Inhibitor p27 / metabolism
  • Eflornithine / pharmacology
  • Enzyme Inhibitors / pharmacology
  • G1 Phase / drug effects
  • G1 Phase / physiology*
  • G2 Phase / drug effects
  • G2 Phase / physiology*
  • HeLa Cells
  • Humans
  • Mitoguazone / analogs & derivatives
  • Mitoguazone / pharmacology
  • Ornithine Decarboxylase / metabolism
  • Ornithine Decarboxylase Inhibitors
  • S Phase / drug effects
  • S Phase / physiology*

Substances

  • Biogenic Polyamines
  • CDKN1B protein, human
  • Enzyme Inhibitors
  • Ornithine Decarboxylase Inhibitors
  • Cyclin-Dependent Kinase Inhibitor p27
  • ethylglyoxal bis(guanylhydrazone)
  • Ornithine Decarboxylase
  • Adenosylmethionine Decarboxylase
  • Mitoguazone
  • Eflornithine